Pioneering the Future of Precision Therapeutics
Harnessing biology, innovation, and translational science to improve patient outcomes.
Technology Platforms
Advancing vaccines, RNA medicines, cell and gene therapies, and precision healthcare technologies.
AI & Bioinformatics
Applying artificial intelligence and computational biology to uncover novel targets, decode immune responses, and accelerate therapeutic development.
Biomanufacturing Excellence
Establishing Biofoundry - scalable facilities and resilient biomanufacturing ecosystems to enable rapid, cost-effective production of next-generation vaccines and personalized medicines.
Mission
To integrate biological engineering with digital analytics, driving our innovation pipeline through three core pillars:
Next Generation Vaccines
Designing next-generation vaccines that deliver robust, safe, and long-lasting immune protection.
Immuno-Oncology
Harnessing the immune system to recognize and eliminate cancer with precision and durability.
.png)
Dr. Sanjay Singh
Founder & CEO
Dr. Sanjay Singh is a distinguished biopharmaceutical innovator and entrepreneur with deep expertise in translational biotechnology, advanced therapeutic platforms, and precision immunotherapy. As the Founder and CEO of Immunoscript Life Sciences Pvt Ltd, he is leading the development of next-generation therapeutic technologies, including advanced cell and gene therapies, engineered immunotherapies, and personalized cancer treatments designed to improve accessibility, scalability, and clinical outcomes.
​
Dr. Singh earned his Ph.D. in Biochemistry from the Central Drug Research Institute and previously worked at the National Institutes of Health, where he contributed to vaccine development and translational immunology research. He has authored numerous scientific publications, holds multiple patents in biotechnology and vaccine development, and has received several national recognitions for innovation and biopharmaceutical product development.
Dr. Kavita Singh
Executive Director & CMO
With over 25 years of experience spanning the biopharmaceutical industry, government agencies, global health, and non-profit sectors, Dr. Kavita Singh brings a 360-degree perspective across scientific innovation, translational research, and public health impact. She brings significant experience in building collaborations across government, regulatory bodies, academia, investors, and industry to translate scientific advances into impactful healthcare solutions. She holds an MBBS and MD in Microbiology, a Postgraduate Diploma in Epidemiology from the Public Health Foundation of India and an Executive Program in Business Management from IIM Kolkata. Her expertise encompasses board-level governance, vaccine and medical countermeasure development, national innovation missions, and large-scale R&D programs.
Dr. Singh has held senior leadership roles including Mission Director of India’s National Biopharma Mission (NBM) and Asia Continental Lead at the Drugs for Neglected Diseases initiative (DNDi), with experience spanning India and the wider Asian region. She has contributed to India’s disease preparedness strategy through government-led initiatives and served as a member of the WHO Product Development for Vaccines Advisory Committee (PDVAC). She also serves as an Independent Director on boards and mentor to women scientists through WomenLift Health and has authored 22 peer-reviewed scientific publications.
